Orforglipron Mechanism of Action
How Orforglipron works: receptor targets, signalling pathways, and molecular profile.
A Non-Peptide GLP-1
Orforglipron is not a peptide — it's a small-molecule, non-peptide compound that activates the GLP-1 receptor, engineered to survive digestion intact and absorb through the gut without the specialized absorption-enhancer technology semaglutide's oral form (Rybelsus) requires. Structurally unrelated to native GLP-1 or exendin-4, it was designed from the ground up as an orally bioavailable small molecule rather than a modified peptide.
No Food or Water Restrictions
The defining practical advantage of orforglipron over Rybelsus (oral semaglutide) is dosing flexibility: it can be taken any time of day, with or without food, with no fasting requirement and no minimum water intake rule. This removes the biggest adherence barrier of the prior oral GLP-1 option, where a missed fasting window meant a missed effective dose.